share_log

EF Hutton Reiterates Buy on Innoviva, Maintains $22.5 Price Target

Benzinga ·  Apr 20, 2023 20:45

EF Hutton analyst Constantine Davides reiterates Innoviva (NASDAQ:INVA) with a Buy and maintains $22.5 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment